Hemophilia gene therapy represents a groundbreaking advance in the treatment of this lifelong bleeding disorder, providing hope to those who manage its challenges daily.For patients like Terence Blue, the introduction of treatments such as Hemgenix marks a significant milestone, potentially alleviating the need for routine clotting factor injections.